Pancreatic size and fat content in diabetes: A systematic review and meta-analysis of imaging studies
- PMID: 28742102
- PMCID: PMC5524390
- DOI: 10.1371/journal.pone.0180911
Pancreatic size and fat content in diabetes: A systematic review and meta-analysis of imaging studies
Abstract
Objectives: Imaging studies are expected to produce reliable information regarding the size and fat content of the pancreas. However, the available studies have produced inconclusive results. The aim of this study was to perform a systematic review and meta-analysis of imaging studies assessing pancreas size and fat content in patients with type 1 diabetes (T1DM) and type 2 diabetes (T2DM).
Methods: Medline and Embase databases were performed. Studies evaluating pancreatic size (diameter, area or volume) and/or fat content by ultrasound, computed tomography, or magnetic resonance imaging in patients with T1DM and/or T2DM as compared to healthy controls were selected. Seventeen studies including 3,403 subjects (284 T1DM patients, 1,139 T2DM patients, and 1,980 control subjects) were selected for meta-analyses. Pancreas diameter, area, volume, density, and fat percentage were evaluated.
Results: Pancreatic volume was reduced in T1DM and T2DM vs. controls (T1DM vs. controls: -38.72 cm3, 95%CI: -52.25 to -25.19, I2 = 70.2%, p for heterogeneity = 0.018; and T2DM vs. controls: -12.18 cm3, 95%CI: -19.1 to -5.25, I2 = 79.3%, p for heterogeneity = 0.001). Fat content was higher in T2DM vs. controls (+2.73%, 95%CI 0.55 to 4.91, I2 = 82.0%, p for heterogeneity<0.001).
Conclusions: Individuals with T1DM and T2DM have reduced pancreas size in comparison with control subjects. Patients with T2DM have increased pancreatic fat content.
Conflict of interest statement
Figures
![Fig 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f884/5524390/7ce275e8255a/pone.0180911.g001.gif)
![Fig 2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f884/5524390/106ea1c1c2e0/pone.0180911.g002.gif)
![Fig 3](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f884/5524390/e4f781787d67/pone.0180911.g003.gif)
![Fig 4](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f884/5524390/8728452f75f0/pone.0180911.g004.gif)
Similar articles
-
Cross-sectional imaging of the pancreas in diabetes.Abdom Radiol (NY). 2024 Jun;49(6):2116-2124. doi: 10.1007/s00261-024-04310-y. Epub 2024 Apr 1. Abdom Radiol (NY). 2024. PMID: 38557767 Review.
-
Association of pancreatic fat content with type II diabetes mellitus.Clin Radiol. 2020 Jan;75(1):51-56. doi: 10.1016/j.crad.2019.05.027. Epub 2019 Nov 8. Clin Radiol. 2020. PMID: 31711639
-
Reduced pancreatic volume in hepatocyte nuclear factor 1A-maturity-onset diabetes of the young.J Clin Endocrinol Metab. 2008 Sep;93(9):3505-9. doi: 10.1210/jc.2008-0340. Epub 2008 Jul 1. J Clin Endocrinol Metab. 2008. PMID: 18593771
-
Altered volume, morphology and composition of the pancreas in type 2 diabetes.PLoS One. 2015 May 7;10(5):e0126825. doi: 10.1371/journal.pone.0126825. eCollection 2015. PLoS One. 2015. PMID: 25950180 Free PMC article. Clinical Trial.
-
Efficacy and safety comparison of rapid-acting insulin aspart and regular human insulin in the treatment of type 1 and type 2 diabetes mellitus: a systematic review.Diabetes Metab. 2011 Jun;37(3):190-200. doi: 10.1016/j.diabet.2010.12.003. Epub 2011 Feb 17. Diabetes Metab. 2011. PMID: 21333580 Review.
Cited by
-
Longitudinal MRI Shows Progressive Decline in Pancreas Size and Altered Pancreas Shape in Type 1 Diabetes.J Clin Endocrinol Metab. 2023 Sep 18;108(10):2699-2707. doi: 10.1210/clinem/dgad150. J Clin Endocrinol Metab. 2023. PMID: 36938587 Free PMC article.
-
Acute Recurrent Pancreatitis in a Child With INS-Related Monogenic Diabetes and a Heterozygous Pathogenic CFTR Mutation.J Endocr Soc. 2022 Dec 12;7(3):bvac182. doi: 10.1210/jendso/bvac182. eCollection 2023 Jan 6. J Endocr Soc. 2022. PMID: 36655002 Free PMC article.
-
Deep learning-based pancreas volume assessment in individuals with type 1 diabetes.BMC Med Imaging. 2022 Jan 5;22(1):5. doi: 10.1186/s12880-021-00729-7. BMC Med Imaging. 2022. PMID: 34986790 Free PMC article.
-
Adipose Tissue Composition in Obesity and After Bariatric Surgery.Obes Surg. 2019 Sep;29(9):3030-3038. doi: 10.1007/s11695-019-04030-z. Obes Surg. 2019. PMID: 31190263 Review.
-
Cross-sectional imaging of the pancreas in diabetes.Abdom Radiol (NY). 2024 Jun;49(6):2116-2124. doi: 10.1007/s00261-024-04310-y. Epub 2024 Apr 1. Abdom Radiol (NY). 2024. PMID: 38557767 Review.
References
-
- Standards of Medical Care in Diabetes-2016: Summary of Revisions. Diabetes care. 2016;39 Suppl 1:S4–5. Epub 2015/12/24. - PubMed
-
- Cnop M, Vidal J, Hull RL, Utzschneider KM, Carr DB, Schraw T, et al. Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes. Diabetes care. 2007;30(3):677–82. Epub 2007/03/01. doi: 10.2337/dc06-1834 - DOI - PubMed
-
- Brozzi F, Nardelli TR, Lopes M, Millard I, Barthson J, Igoillo-Esteve M, et al. Cytokines induce endoplasmic reticulum stress in human, rat and mouse beta cells via different mechanisms. Diabetologia. 2015;58(10):2307–16. Epub 2015/06/24. doi: 10.1007/s00125-015-3669-6 - DOI - PubMed
-
- Butler AE, Janson J, Soeller WC, Butler PC. Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes. 2003;52(9):2304–14. Epub 2003/08/28. - PubMed
-
- Donath MY, Halban PA. Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia. 2004;47(3):581–9. Epub 2004/02/10. doi: 10.1007/s00125-004-1336-4 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical